Hong Kong (HSI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Feb 02, 2025

Explore the Hong Kong (HSI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

104 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
9926
Akeso
HK$60.851.8%52.5%HK$54.6bHK$76.64PS27.1xE43.8%n/a
2228
XtalPi Holdings
HK$5.205.1%n/aHK$17.7bHK$8.58PS83.6xE90.7%n/a
3692
Hansoh Pharmaceutical Group
HK$17.880.7%57.1%HK$106.1bHK$23.64PE20.9xE6.4%2.2%
2509
Qyuns Therapeutics
HK$9.6020.2%n/aHK$2.1bn/aPS33.2xn/an/a
1548
Genscript Biotech
HK$10.681.3%-16.8%HK$22.9bHK$22.72PS2.9xE111.3%0%
775
CK Life Sciences Int'l. (Holdings)
HK$0.525.1%0%HK$5.0bn/aPB1.2xn/a0%
3933
United Laboratories International Holdings
HK$11.540.7%67.0%HK$21.0bHK$12.11PE6.7xE5.2%5.2%
2410
TYK Medicines
HK$23.001.5%n/aHK$8.5bn/aPE-18.5xn/an/a
2315
Biocytogen Pharmaceuticals (Beijing)
HK$7.874.0%-11.4%HK$3.1bHK$13.49PS3.7xS22.4%n/a
2487
Cutia Therapeutics
HK$4.367.7%-32.9%HK$1.4bHK$14.61PS6.5xE49.4%n/a
2142
HBM Holdings
HK$3.663.7%128.8%HK$2.7bn/aPE16.2xn/an/a
460
Sihuan Pharmaceutical Holdings Group
HK$0.591.7%15.7%HK$5.5bn/aPS2.9xn/a6.9%
1801
Innovent Biologics
HK$33.050.2%3.4%HK$54.1bHK$53.99PS6.8xE44.3%n/a
2633
Jacobson Pharma
HK$1.262.4%113.6%HK$2.5bn/aPE9.9xn/a5.6%
1681
Consun Pharmaceutical Group
HK$7.870.6%48.5%HK$6.5bHK$10.20PE7.3xE14.7%7.4%
2480
Beijing Luzhu Biotechnology
HK$24.200.8%-13.4%HK$4.9bHK$30.65PB4.8xE50.4%n/a
1061
Essex Bio-Technology
HK$2.882.1%20.0%HK$1.6bHK$5.12PE6.2xE6.2%4.2%
8225
China Health Group
HK$0.1910.5%22.6%HK$189.1mn/aPS7.1xn/an/a
3737
Zhongzhi Pharmaceutical Holdings
HK$1.022.0%-18.4%HK$880.9mn/aPE7.4xn/a0%
6998
Genor Biopharma Holdings
HK$1.881.6%86.1%HK$971.2mn/aPS62.5xn/an/a
2257
Sirnaomics
HK$2.894.3%-90.3%HK$301.6mHK$72.10PS35.9xS50.7%n/a
950
Lee's Pharmaceutical Holdings
HK$1.231.7%-5.4%HK$724.3mn/aPE11.5xn/a2.4%
897
Wai Yuen Tong Medicine Holdings
HK$0.323.3%-24.1%HK$354.4mn/aPE171xn/a9.5%
2566
Hangzhou Jiuyuan Gene Engineering
HK$5.840.7%n/aHK$1.4bn/aPE10.4xn/an/a
Page 1 of 5